SPARK NS awards five projects up to $10 million to advance academic discoveries in Parkinson’s disease
- SPARK NS announced five projects selected for the 2024 Parkinson’s Disease Translational Research Program.
- Each project will receive up to $2 million in milestone-based funding over two years.
- The program includes education, mentoring, and networking opportunities to aid drug development.
- Selected projects focus on reducing alpha synuclein spread, designing small molecule degraders, enhancing autophagy, preventing dopamine-induced neurotoxicity, and axonal reinnervation therapy.
Read more
